Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

Overview
Date Founded

1944

Headquarters

408 Tashiro Daikan-machi,Tosu, Saga 841-0017

Type of Company

Public

Employees (Worldwide)

2,745

Industries

Pharmaceuticals

Company Description

Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.

Executives & Employees

Chairman & Chief Executive Officer

President, Chief Operating Officer, Representative Director

Director, Executive Officer, Head of BU Division & General Manager of Finance & Accounting, IR & CSR

Managing Director, General Manager-Research & Development

Director

MD, Executive Officer & Head-Operations

Senior MD, Executive Officer & Head-Personnel

Director

Executive Officer & Manager-Corporate Strategy

Board of Directors

Chairman & Chief Executive Officer at Hisamitsu Pharmaceutical Co., Inc.

Chief Executive Officer at Noven Pharmaceuticals, Inc.

Director, Executive Officer, Head of BU Division & General Manager of Finance & Accounting, IR & CSR at Hisamitsu Pharmaceutical Co., Inc.

MD, Executive Officer & Head-Operations at Hisamitsu Pharmaceutical Co., Inc.

Director at Hisamitsu Pharmaceutical Co., Inc.

Senior MD, Executive Officer & Head-Personnel at Hisamitsu Pharmaceutical Co., Inc.

President, Chief Operating Officer, Representative Director at Hisamitsu Pharmaceutical Co., Inc.

Independent Outside Director at Hisamitsu Pharmaceutical Co., Inc.

Former Senior Managing Representative Director at The Mitsubishi Bank Ltd.

Paths to Hisamitsu Pharmaceutical Co., Inc.
Potential Connections via
Relationship Science
You
Hisamitsu Pharmaceutical Co., Inc.
Owners & Shareholders
Details Hidden

IAMJ is a GARP-oriented investment manager which invests in global equity and debt across market caps and sectors, with the bulk of their investments in Japanese large-cap equity. The firm performs fundamental and quantitative analysis, tactical asset allocation and absolute returns. Their investment process starts with a top-down selection of sectors, followed by bottom-up stock picking. IAMJ’s research is primarily done by the internal analysts and portfolio managers.

Details Hidden

IAMJ is a GARP-oriented investment manager which invests in global equity and debt across market caps and sectors, with the bulk of their investments in Japanese large-cap equity. The firm performs fundamental and quantitative analysis, tactical asset allocation and absolute returns. Their investment process starts with a top-down selection of sectors, followed by bottom-up stock picking. IAMJ’s research is primarily done by the internal analysts and portfolio managers.

Recent Transactions
Details Hidden

Hisamitsu Pharmaceutical Co., Inc. purchases Yutoku Pharmaceutical Ind Co. Ltd.

Details Hidden

Hisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Details Hidden

I'rom Group Co., Ltd., I'rom Pharmaceutical Co., Ltd. purchase Hisamitsu Pharmaceutical Co., Inc. /MVI Business from Hisamitsu Pharmaceutical Co., Inc.

Transaction Advisors
Legal Advisor

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Legal Advisor

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Proxy Solicitor

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Proxy Solicitor

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Attorney

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Associate

Advised onHisamitsu Pharmaceutical Co., Inc., Northstar Merger Sub, Inc. purchase Noven Pharmaceuticals, Inc.

Clients

Ohki Health Care Holdings, Inc. operates as a holding company which manages the activities of its subsidiaries. It specializes in the manufacture and sale of pharmaceutical products. The company was founded by Kotetsu Ohki on June 17, 1658 and is headquartered in Tokyo, Japan.

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2020
Market Capitalization
$4.79B
Total Enterprise Value
$2.4B
Earnings Per Share
$2.11
EBITDAMargin
19.14%
Enterprise Value EBITDAOperating
9.6x
TEVNet Income
13.85x
Debt TEV
0.01x
Enterprise Value / Sales
1.84x
Three Year Compounded Annual Growth Rate Of Revenue
-1.14%
Revenue
$1.31B
Net Profit
$173M
Total Debt
$16.5M
EBITDA
$250M
Total Equity
$2.32B
Investments
Details Hidden

Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan.

Suppliers
Maruto Sangyo Co., Ltd. Plastics & Synthetics | Ogori, Japan

Maruto Sangyo Co., Ltd. engages in the manufacturing and sale of packaging materials. Its products include single and laminate films, wrapping paper, paper board boxes, label seals, plastic molding, gravure printing, plastic products and containers, gardening and agricultural materials, and packaging and industrial machinery. It also offers design, construction and sale of synthetic resin flooring, mechanical equipment installation, and planning and production of advertising and package design. The company was founded on October 1, 1939 and is headquartered in Ogori, Japan.

Sanofi Pharmaceuticals | Paris, France

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Yutoku Pharmaceutical Ind Co. Ltd. Wholesale: Consumer Non-Durables/Sundries | Kashima, Japan

Yutoku Pharmaceutical Ind Co. Ltd. is a private company headquartered in Kashima, Japan, that manufactures and wholesales pharmaceutical drugs and medical devices.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hisamitsu Pharmaceutical Co., Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hisamitsu Pharmaceutical Co., Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hisamitsu Pharmaceutical Co., Inc..